Scopus
🔓 Açık Erişim YÖKSİS Eşleşti
Periprocedural Mortality in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the PROGRESS-CTO Registry
Circulation: Cardiovascular Interventions · Haziran 2023
YÖKSİS Kayıtları
Periprocedural Mortality in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry
Circulation: Cardiovascular Interventions · 2023 SSCI
PROFESÖR NAZİF AYGÜL →
Makale Bilgileri
DergiCirculation: Cardiovascular Interventions
Yayın TarihiHaziran 2023
Cilt / Sayfa16 · E012977
Scopus ID2-s2.0-85163398362
Erişim🔓 Açık Erişim
Özet
Background: Death is a rare but devastating complication of chronic total occlusion (CTO) percutaneous coronary intervention. Methods: We examined the clinical characteristics and procedural outcomes of patients who died periprocedurally in the Prospective Global Registry for the Study of CTO Interventions (PROGRESS-CTO). Results: Of the 12 928 patients who underwent CTO percutaneous coronary intervention between 2012 and 2022, 52 (0.4%) died during the index hospitalization. Patients who died were more likely to have a history of heart failure (43% versus 28%; P=0.023). The J-CTO ([Multicenter CTO Registry of Japan]; 2.8±1.1 versus 2.4±1.3; P=0.019), PROGRESS-CTO mortality (2.6±0.9 versus 1.6±1.1; P<0.001), and PROGRESS-CTO pericardiocentesis (2.9±1.1 versus 1.9±1.3; P<0.001) scores were higher in patients who died. In these patients, the use of left ventricular assist devices was also higher (41% versus 3.5%; P<0.001), and retrograde crossing was more often the first crossing strategy (33% versus 13%; P<0.001). The cause of death was cardiac in 43 patients (83%) and noncardiac in 9 patients (17%). Complications leading to cardiac death were: tamponade in 30 patients (58%), acute myocardial infarction in 9 (17.3%), and cardiac arrest/shock in 4 (7.7%). Noncardiac causes of death were: stroke in 3 (5.8%), renal failure in 2 (3.8%), respiratory distress in 2 (3.8%), and hemorrhagic shock in 2 (3.8%). Conclusions: Approximately 0.4% of patients who underwent CTO percutaneous coronary intervention died during the index hospitalization. The main cause of death was tamponade in 58%. PROGRESS-CTO complication scores might help in risk stratification and procedural planning in patients undergoing CTO percutaneous coronary intervention. Registration: URL: https://www.clinicaltrials.gov; Unique Identifier: NCT02061436.
Yazarlar (30)
1
Bahadir Simsek
2
Athanasios Rempakos
3
Spyridon Kostantinis
4
Judit Karacsonyi
5
Sevket Gorgulu
6
Khaldoon Alaswad
7
James W. Choi
8
Farouc A. Jaffer
9
Darshan Doshi
ORCID: 0000-0002-7817-7485
10
Paul Poommipanit
11
Nazif Aygül
12
Oleg Krestyaninov
13
Dmitrii Khelimskii
14
Barry Uretsky
15
Rhian Davies
16
Omer Goktekin
17
Ahmed M. ElGuindy
18
Brian K. Jefferson
19
Taral Patel
20
Mitul Patel
21
Abdul Sheikh
22
Dimitrios Karmpaliotis
23
Srinivasa Potluri
24
Karim M. Al-Azizi
ORCID: 0000-0003-0195-4984
25
Olga C. Mastrodemos
26
Bavana V. Rangan
27
Salman S. Allana
28
Yader Sandoval
29
M. Nicholas Burke
30
Emmanouil S. Brilakis
Anahtar Kelimeler
cause of death
death
mortality
percutaneous coronary intervention
Kurumlar
Aswan Heart Centre
Aswan Egypt
Biruni Üniversitesi
Istanbul Turkey
Centennial Medical Center
Nashville United States
E.N. Meshalkin National Medical Research Center
Novosibirsk Russian Federation
Harvard Medical School
Boston United States
Henry Ford Hospital
Detroit United States
Memorial Bahcelievler Hospital
Istanbul Turkey
Minneapolis Heart Institute
Minneapolis United States
Morristown Medical Center
Morristown United States
Selçuk Üniversitesi
Selçuklu Turkey
Texas Health Presbyterian Hospital
Dallas United States
The Heart Hospital Baylor Plano
Plano United States
UAMS College of Medicine
Little Rock United States
UCSD Medical Center-Hillcrest
San Diego United States
University Hospitals Case Medical Center
Cleveland United States
WellSpan York Hospital
York United States
Wellstar Health System
Marietta United States
Metrikler
4
Atıf
30
Yazar
4
Anahtar Kelime